title: Pulmonary Hypertension and Atrial Septal Defect: Management Dilemma.
abstract: The decision making in patients with an atrial septal defect (ASD) in setting of pulmonary hypertension is complex. In the era of pulmonary arterial vasodilator therapy, every patient should undergo evaluation by pulmonary hypertension experts especially if defect closure is being considered. Defect closure in the inappropriate group can lead to poor outcomes.
authors: 1Department of Medicine, Division of Pulmonary, Critical Care and Sleep Disorders Medicine, University of Louisville, Louisville, KY; 2Department of Medicine, Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; and 3Department of Medicine, Division of Cardiology, University of Louisville, Louisville, KY.
authors: Karim
authors: K
authors: El-Kersh
authors: Molly
authors: M
authors: Howsare
authors: Ali
authors: A
authors: Zaidi
authors: Michael P
authors: MP
authors: Flaherty
authors: J Shaun
authors: JS
authors: Smith
mesh_terms: D000328:Adult; D006328:Cardiac Catheterization; D004417:Dyspnea / Q000209:etiology / Q000628:therapy; D015150:Echocardiography, Doppler; D017548:Echocardiography, Transesophageal; D005260:Female; D006344:Heart Septal Defects, Atrial / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D006352:Heart Ventricles / Q000473:pathology*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D000860:Hypoxia / Q000209:etiology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000209:etiology; D011651:Pulmonary Artery; D012086:Reoperation; D055989:Septal Occluder Device / Q000009:adverse effects*; D060205:Therapeutic Occlusion / Q000009:adverse effects* / Q000295:instrumentation / Q000379:methods; D014057:Tomography, X-Ray Computed; D014665:Vasodilator Agents / Q000627:therapeutic use*; D016276:Ventricular Function
chemical_list: D014665:Vasodilator Agents